We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LNC:NYSELincoln National Corporation analysis

Data as of Sep 20, 2026 - not real-time

Latest price
$42.20
Risk: medium
5/10Medium risk

Summary

The moving-average structure behind Lincoln National Corporation is neutral at $42.20, with no clear ordering between short and long averages. The last 30 days have lost 9.6%. Momentum indicators put RSI at 42.6 (neutral) with MACD reading bearish. Recent trading has carved out support near $41.46 and resistance around $45.90.
The shares look undervalued, trading on 3.6 times earnings below a sector average of 15.8. Analyst price targets sit 13.5% above the current price. Revenue is growing at 12.6% on a 12.2% profit margin. The 4.27% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 30.0%, a beta of 1.09 and a maximum drawdown of 29.9%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 8/10.

Top market events

  • LNC stock reflects investors’ cautious view on Lincoln National Corporation as the insurer works thr
  • Lincoln National stock trades near recent levels on the NYSE as of September 16, 2026 while investor
  • Lincoln National stock recently reflected mixed sentiment after its latest quarterly results and div

Market outlook

Short term

< 1 year

Positive

Model confidence5/105 out of 10

Key factors

  • Trading above the 200-day average of 39.55
  • MACD momentum is negative
  • 30-day price change of -9.6%

Medium term

1–3 years

Positive

Model confidence6/106 out of 10

Key factors

  • P/E of 3.6 versus sector average of 15.8
  • Trading above the 200-day average of 39.55
  • Analyst targets imply +13.5% versus the current price

Long term

> 3 years

Positive

Model confidence8/108 out of 10

Key factors

  • P/E of 3.6 versus sector average of 15.8
  • Analyst targets imply +13.5% versus the current price
  • Revenue growth of +12.6%

Key metrics

Financial health

Revenue Growth12.60%
Profit Margin12.17%
P/E Ratio3.6
ROE22.59%
ROA0.28%
Debt/Equity63.80
P/B Ratio0.8
Op. Cash Flow$-1328000000
Free Cash Flow$2.1B
Industry P/E15.8

Technical analysis

TrendNeutral
RSI42.6
Support$41.46
Resistance$45.90
MA 20$43.33
MA 50$43.41
MA 200$39.55
MACDBearish
VolumeIncreasing
Fear & Greed Index94.98

Valuation

Fair Value$426.02
Target Price$47.92
Upside/Downside13.55%
GradeUndervalued
TypeValue
Dividend Yield4.27%

Risk assessment

Beta1.09
Volatility30.04%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.